Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 1
2006 4
2008 3
2009 1
2010 3
2011 4
2013 3
2014 6
2015 5
2016 4
2017 7
2018 10
2019 10
2020 8
2021 16
2022 10
2023 8
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean huang chun yang (66 results)?
Prevalence of Dyslipidemia and Availability of Lipid-Lowering Medications Among Primary Health Care Settings in China.
Lu Y, Zhang H, Lu J, Ding Q, Li X, Wang X, Sun D, Tan L, Mu L, Liu J, Feng F, Yang H, Zhao H, Schulz WL, Krumholz HM, Pan X, Li J; China Patient-Centered Evaluative Assessment of Cardiac Events Million Persons Project Collaborative Group. Lu Y, et al. JAMA Netw Open. 2021 Sep 1;4(9):e2127573. doi: 10.1001/jamanetworkopen.2021.27573. JAMA Netw Open. 2021. PMID: 34586366 Free PMC article.
COPD and T2DM: a Mendelian randomization study.
Wang T, Li J, Huang C, Wu X, Fu X, Yang C, Li M, Chen S. Wang T, et al. Among authors: huang c. Front Endocrinol (Lausanne). 2024 Feb 8;15:1302641. doi: 10.3389/fendo.2024.1302641. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38390207 Free PMC article.
Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations: final analysis of the prospective phase 2, multicenter ALTER-L004 study.
Zhang L, Wang L, Wang J, Chen J, Meng Z, Liu Z, Jiang X, Wang X, Huang C, Chen P, Liang Y, Jiang R, Wang J, Zhong D, Shang Y, Zhang Y, Zhang C, Huang D. Zhang L, et al. Among authors: huang c. Mol Cancer. 2023 Aug 5;22(1):124. doi: 10.1186/s12943-023-01823-w. Mol Cancer. 2023. PMID: 37543587 Free PMC article. Clinical Trial.
99 results